idoxuridine has been researched along with alovudine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bussink, J; Kaanders, JH; Merkx, MA; Oyen, WJ; Peeters, WJ; Slootweg, PJ; Troost, EG; van der Kogel, AJ | 1 |
| Ametamey, SM; André, PA; Bischof Delaloye, A; Buchegger, F; Dupertuis, YM; Kosinski, M; Perillo-Adamer, F; Ross, TL; Viertl, D | 1 |
2 other study(ies) available for idoxuridine and alovudine
| Article | Year |
|---|---|
Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.
Topics: Biomarkers; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Humans; Idoxuridine; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Mouth Neoplasms; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Thymidine Kinase; Tomography, Emission-Computed | 2010 |
18F-FLT and 125I-IdUrd uptake increase in human tumour cell lines induced by the thymidylate synthase inhibitor FdUrd.
Topics: Cell Line, Tumor; Dideoxynucleosides; Floxuridine; Humans; Idoxuridine; Metabolic Clearance Rate; Nucleoside-Phosphate Kinase; Radionuclide Imaging; Radiopharmaceuticals | 2012 |